Hematopoeitic cell transplantation and CAR T-cell therapy: Complements or competitors?

Authors

Scott R Goldsmith, Washington University School of Medicine in St. Louis
Armin Ghobadi, Washington University School of Medicine in St. Louis
John F DiPersio, Washington University School of Medicine in St. Louis

Journal

Frontiers in Oncology

Publication Date

1-1-2020

Volume

10

First Page

608916

Document Type

Open Access Publication

DOI

10.3389/fonc.2020.608916

Rights and Permissions

Goldsmith SR, Ghobadi A and DiPersio JF (2020) Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors? Front. Oncol. 10:608916. doi: 10.3389/fonc.2020.608916 © 2020 Goldsmith, Ghobadi and DiPersio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Goldsmith, Scott R; Ghobadi, Armin; and DiPersio, John F, "Hematopoeitic cell transplantation and CAR T-cell therapy: Complements or competitors?." Frontiers in Oncology. 10, 608916 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/10051